Ras overexpression has been found in more than 15% of human tumors [15], since its upregulation can promote cancer cell proliferation by the deregulation of the basal activation levels of the MAPK, phosphatidylinositol 3-kinase (PI3K), and phospholipase C epsilon (PLCε) pathways [15]. Here, PLCL1 is linked to cancer.